MIPS Program Awards $4.7 Million to Maryland University Researchers
The University of Maryland's Maryland Industrial Partnerships (MIPS) program today announces it is awarding $4.7 million to Maryland university researchers to help 16 local companies develop technology products.
The projects, which team companies with universities across the state, include gene-silencing for cancer treatment, a new cardiovascular diagnostic device, advanced chemical detection, distributed heating and cooling, fertilizers and soil amendments made from both fish waste and other mixtures, agricultural stormwater treatment, an heirloom tomato juice production system, temperature-detecting gel, a drug to treat lung fibrosis, advanced oyster seeding system, electronic baseball home plate, mobile solar milk chiller, and both a vehicle and sensor technology for inspecting bridges.
Companies are contributing $3.3 million and MIPS $1.4 million to the jointly funded projects. The Maryland Department of Natural Resources and the Environmental Protection Agency provided additional funding. All funding goes to support the work of faculty and graduate students for each project.
For the first time, projects include researchers from St. Mary's College of Maryland and Morgan State University.
Winning projects, listed by company, location, participating faculty, funding amount, and description, include:
This is the 51st round of MIPS grants. Projects are co-funded by MIPS and participating companies.
Part of the Maryland Technology Enterprise Institute (Mtech), an initiative of the A. James Clark School of Engineering at the University of Maryland, MIPS is in its 26th year, providing matching grants for technology product development projects that team Maryland companies with researchers in Maryland public universities.
Blockbuster and emerging products developed by Maryland companies have benefitted from MIPS, including Martek Biosciences’ nutritional oils, Hughes Communications’ HughesNet™, MedImmune’s Synagis®, Black & Decker’s Bullet® Speed Tip Masonry Drill Bit, WellDoc's mobile diabetes management platform, and CSA Medical's diseased-tissue ablation device. Products with MIPS projects have generated more than $25.2 billion in revenue and added thousands of jobs to the region.
MIPS has supported research projects with more than 500 different Maryland companies since 1987.
MIPS recently released results from an independent study titled "An Analysis of the Impacts of MIPS Program Spending and the Commercialization of MIPS Funded Projects on the State of Maryland," by Richard Clinch, from the Jacob France Institute at the University of Baltimore. That study found that:
Read the full report online here: http://mips.umd.edu/docs/reports/JFI_MIPS_Report_2012.pdf.
February 20, 2013